US 12012463
High affinity monoclonal antibodies targeting glypican-2 and uses thereof
granted A61KA61K2039/505A61K2239/31
Quick answer
US patent 12012463 (High affinity monoclonal antibodies targeting glypican-2 and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K2239/47